Invitation to Surgical Science’s Capital Markets Day 2023

Surgical Science is pleased to invite shareholders and investors to its Capital Markets Day on Wednesday, February 22, 2023 at 14:00-17:30 CET.

VENUE
Royal Park, Stockholm, Sweden
Frösundaviks allé 15, 169 03 Solna

AGENDA
▪ 14.00: Gisli Hennermark CEO, welcome
▪ 14.20: Anna Ahlberg CFO and Gisli Hennermark CEO, presentation of the Q4 report
▪ 14.50: Ran Bronstein President, R&D, reflections on joining Surgical Science
▪ 15.10: Dr. Mark Slack CMO and Co-founder CMR Surgical, transforming surgery and the role of simulation
▪ 16.00: Dr. Henrik Falconer Chief Physician and Associate Professor Karolinska University Hospital,
robotic surgery and simulation
▪ 16.30: Gisli Hennermark, closing remarks
▪ 16.35-17.30: Demo of simulators and products

If you would like to attend or have any questions regarding this event, please send an email to: [e-mail]

Gothenburg, Sweden, January 19, 2023
Surgical Science Sweden AB (publ)

The invitation, in its entirety, is available through the attachment or via:
https://surgicalscience.com/aktien/pressmeddelanden/

For further information, please contact:

---

Gisli Hennermark, CEO
Telephone: [phone]
E-mail: [e-mail]

Anna Ahlberg, CFO
Telephone: [phone]
E-mail: [e-mail]

About Surgical Science Sweden AB (publ)

---

One of the biggest challenges within healthcare globally is how injuries during care can be reduced. Medical education and training are key, as a large part of the training today can be performed outside the operating room. Surgical Science is a world leader in the manufacture of virtual reality simulators for evidence-based training. The simulators enable surgeons and other medical specialists to train and improve their psychomotor skills and instrument handling before entering the clinical environment. In parallel with its own products, Surgical Science works with simulation solutions for medical technology companies that develop surgical instruments for clinical use, such as robotic surgery.

Surgical Science has approximately 230 employees. The company is headquartered in Gothenburg, Sweden and also has operations in Stockholm, Sweden, as well as in Tel Aviv, Israel and Seattle, US. Through sales offices in the US, France and China as well as a global network of distributors, Surgical Science maintains a presence in most markets. Surgical Science Sweden AB (publ) is traded on Nasdaq First North Growth Market. Certified Adviser is Erik Penser Bank (Phone: [phone]; E-mail: [e-mail]).

Attachments

---

Invitation To Surgical Science Capital Markets Day 2023

© Modular Finance, source Nordic Press Releases